Recent Advances in AIEgen‐Based Photodynamic Therapy and Immunotherapy

Abstract Cancer, one of the leading causes of death, has seriously threatened public health. However, there is still a lack of effective treatments. Nowadays, photodynamic therapy (PDT), relying on photosensitizers to trigger the generation of reactive oxygen species (ROS) for killing cancer cells, has been emerging as a noninvasive anti‐cancer strategy. To enhance the overall anti‐cancer efficacy of PDT, various approaches including molecular design and combination with other therapeutic techniques have been proposed and implemented. Especially, photodynamic immunotherapy that can effectively evoke the body's immune response has attracted much attention. Recently, a class of photosensitizers with aggregation‐induced emission (AIE) character have shown unique promises, taking advantage of their profound fluorescence and ROS‐generating ability in the aggregation state. Despite the promising results demonstrated by several groups, the associated studies are few and the mechanism of such AIEgen‐based photodynamic immunotherapy has not been fully understood. This review discusses the recent advances in the AIEgen‐based enhanced PDT with a special focus on the AIE photosensitizers for photodynamic immunotherapy, aiming to inspire more opportunities for in‐depth investigation of the working principles in this emerging anti‐cancer approach.